PLEASE REVIEW BOTH DISCUSSION 1 and 2 review information provide for this assignment i need you to to response to the discussion
The response should be a substantive interaction that builds on the ideas of others, delving deeper into the discussion question and course content in response to a colleague in a very positive tone NOT NEGATIVE PLEASE. The response includes one reference from a professional peer-reviewed scholarly journal.
Discussion 1
Compliment on why you agree with listed information in the discussion and also provide objective examples to support
Discussion 2
Compliment on why you agree with the listed information in discussion 2 and also provide objective examples to support
Please use a peer reviewed scholarly journal or article to support response that is no more than 4 years old
DISCUSSION 1 INFORMATION
In 13-17 year old females with depression (P), how does medication (I) compared with no medication (C) affect quality of life (O) within three months (T)?
As you can see my intervention was focused on providing the patient with medication that can be helpful in managing depression and helping improve their quality of life. In my research for a practice guideline or best practice that supported my intervention I came across one, titled Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts. This guideline focused on three different population groups, one of them being adolescents. One of the recommendation that was listed in the guideline was the use of Fluoxetine as a first line medication compared to other medications (American Psychological Association, 2019). In my opinion this recommendation is key to my intervention, since I want to see if medication will help 13-17 year old adolescent with depression have a more “normal” and productive daily living. Knowing that there is a medication that will provide some kind of health improvement to the patients makes me hopeful about the outcome of my question.
Link to Guideline: https://www.guidelinecentral.com/guideline/19889/#section-anchor-335988
Links to an external site.
Another source was found that also supports the guideline that was described in the above paragraph. Hazell (2021) mentions that despite the wide range of choices available, there is only a limited number of interventions that are effective initially for children and adolescents with depression. Hazell continues on by saying that the results of a meta-analysis including pharmacological and psychological therapies (71 trials, 9510 participants) showed that fluoxetine is a successful first-line antidepressant mono-therapy for children and adolescents (Hazell, 2021).
Finding ways to help these young adolescents that may be presenting with depression, is the main priory of my PICOT question. So far literature has demonstrated that the use of Fluoxetine is one way that this problem can be tackled.
References
American Psychological Association. (2019). Clinical practice guideline for the treatment of depression across three age cohorts. Retrieved from https://www-apa-org.ezproxylocal.library.nova.edu/depression-guideline/guideline.pdf
Links to an external site.
Hazell, P. (2021). Updates in treatment of depression in children and adolescents. Current Opinion in Psychiatry, 34(6), 593–599. https://doi.org/10.1097/yco.0000000000000749
Links to an external site.
DISCUSSION 2
In pregnant low-income adolescents (P) experiencing perinatal depression, how does weekly psychotherapy (I) compared with no treatment (C) affect depression levels (O) in six months (T)?
The guideline supports my intervention as it summarizes treatments for depression across three age cohorts and recommends two types of psychotherapy for treating adolescents.
Link to clinical practice guideline: https://doiorg.ezproxylocal.library.nova.edu/10.1037/amp0000904
Links to an external site.
The PICOT question recommends weekly psychotherapy as the intervention to treat perinatal adolescent depression. The recommendation for treating adolescents with depression is psychotherapy (Guideline Development Panel for the Treatment of Depressive Disorders, 2021). Specifically, cognitive behavior therapy and interpersonal psychotherapy are supported by evidence from randomized control trials (RCTs) that show decreased levels of depression in adolescents (Guideline Development Panel for the Treatment of Depressive Disorders, 2021). The guidelines also mention important factors which can influence the outcome of a treatment plan. These factors include, speaking to the patient about barriers faced in the search for proper care. Some examples are cost of treatment, transportation issues, dealing with the stigma surrounding mental health, and cultural challenges. It’s important for the mental health practitioner to help guide the patient through such barriers to create the most personalized and optimal treatment plan for them. Also stressed is getting proper informed consent before treatment. In adolescents the parent must be informed of the treatment plan and consent for that child. The adolescent must be informed as well and assent to the treatment plan. The guideline discusses treatment of depression for varying age groups using practitioners’ expertise, patient preference, culture, and values as well as the best current research (Guideline Development Panel for the Treatment of Depressive Disorders, 2021).
Reference
Guideline Development Panel for the Treatment of Depressive Disorders (2021). Summary of the clinical practice guideline for the treatment of depression across three age cohorts. The American Psychologist, 1-13. https://doiorg.ezproxylocal.library.nova.edu/10.1037/amp0000904
Links to an external site.
???? Hi, how can I help?
